View in EDS

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer.

Saved in:
Bibliographic Details
Title: Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer.
Authors: Kao J (AUTHOR), Genden EM (AUTHOR), Chen CT (AUTHOR), Rivera M (AUTHOR), Tong CC (AUTHOR), Misiukiewicz K (AUTHOR), Gupta V (AUTHOR), Gurudutt V (AUTHOR), Teng M (AUTHOR), Packer SH (AUTHOR)
Source: Cancer (0008543X). 7/15/2011, Vol. 117 Issue 14, p3173-3181. 9p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first